AP2774A - Substituted (pyrazolylcarbonyl) imidazolidinones and their uses - Google Patents

Substituted (pyrazolylcarbonyl) imidazolidinones and their uses

Info

Publication number
AP2774A
AP2774A AP2010005422A AP2010005422A AP2774A AP 2774 A AP2774 A AP 2774A AP 2010005422 A AP2010005422 A AP 2010005422A AP 2010005422 A AP2010005422 A AP 2010005422A AP 2774 A AP2774 A AP 2774A
Authority
AP
ARIPO
Prior art keywords
pyrazolylcarbonyl
imidazolidinones
substituted
Prior art date
Application number
AP2010005422A
Other languages
English (en)
Other versions
AP2010005422A0 (en
Inventor
Kai Thede
Susanne Greschat
Steffen Wildum
Original Assignee
Aicuris Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aicuris Gmbh & Co Kg filed Critical Aicuris Gmbh & Co Kg
Publication of AP2010005422A0 publication Critical patent/AP2010005422A0/en
Application granted granted Critical
Publication of AP2774A publication Critical patent/AP2774A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AP2010005422A 2008-03-17 2009-03-10 Substituted (pyrazolylcarbonyl) imidazolidinones and their uses AP2774A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102008015033A DE102008015033A1 (de) 2008-03-17 2008-03-17 Substituierte (Pyrazolyl-carbonyl)imidazolidinone und ihre Verwendung
PCT/EP2009/001714 WO2009115213A1 (fr) 2008-03-17 2009-03-10 Dérivés de (pyrazolyl-carbonyl)imidazolidinone pour le traitement de maladies rétrovirales

Publications (2)

Publication Number Publication Date
AP2010005422A0 AP2010005422A0 (en) 2010-10-31
AP2774A true AP2774A (en) 2013-09-30

Family

ID=40565083

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2010005422A AP2774A (en) 2008-03-17 2009-03-10 Substituted (pyrazolylcarbonyl) imidazolidinones and their uses

Country Status (22)

Country Link
US (1) US8399682B2 (fr)
EP (1) EP2254885B1 (fr)
JP (1) JP5576853B2 (fr)
KR (1) KR20100124337A (fr)
CN (1) CN101977908B (fr)
AP (1) AP2774A (fr)
AR (1) AR070919A1 (fr)
AU (1) AU2009226656A1 (fr)
CA (1) CA2718685C (fr)
CL (1) CL2009000636A1 (fr)
DE (1) DE102008015033A1 (fr)
IL (1) IL207649A0 (fr)
MA (1) MA32224B1 (fr)
MX (1) MX2010010230A (fr)
NZ (1) NZ588141A (fr)
PE (1) PE20091718A1 (fr)
RU (1) RU2010141578A (fr)
TW (1) TW200951125A (fr)
UA (1) UA102390C2 (fr)
UY (1) UY31717A1 (fr)
WO (1) WO2009115213A1 (fr)
ZA (1) ZA201007361B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008015033A1 (de) 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituierte (Pyrazolyl-carbonyl)imidazolidinone und ihre Verwendung
DE102008015032A1 (de) 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituierte Pyrazolamide und ihre Verwendung
DE102008062878A1 (de) 2008-12-17 2010-06-24 Aicuris Gmbh & Co. Kg Substituierte Furancarboxamide und ihre Verwendung
DE102008062863A1 (de) 2008-12-17 2010-06-24 Aicuris Gmbh & Co. Kg Substituierte (Thiophenyl-carbonyl)imidazolidinone und ihre Verwendung
EP2295038B1 (fr) * 2009-09-11 2013-05-29 AiCuris GmbH & Co. KG Dispersion solide comprenant un agent anti-VIH
DE102011055815A1 (de) * 2011-11-29 2013-05-29 Aicuris Gmbh & Co. Kg Carboxamid-substituierte Heteroaryl-Pyrazole und ihre Verwendung
DE102012016908A1 (de) 2012-08-17 2014-02-20 Aicuris Gmbh & Co. Kg Tris-(Hetero)Aryl-Pyrazole und ihre Verwendung

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002100853A1 (fr) * 2001-06-04 2002-12-19 F. Hoffmann-La Roche Ag Derives de pyrazole utilises comme inhibiteurs de la transcriptase inverse du vih
WO2004024147A1 (fr) * 2002-09-16 2004-03-25 Pfizer Limited Derives de 4-(3,5-dicyanophenoxy)pyrazole utilises comme modulateurs de la transcriptase inverse dans le traitement, entre autres, du vih
WO2004031178A1 (fr) * 2002-10-07 2004-04-15 Pfizer Limited Derives de pyrazole
US20050054707A1 (en) * 2003-09-05 2005-03-10 Pfizer Inc. Pyrazole derivatives

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB453061A (en) 1935-03-23 1936-09-04 Charles Howard Twigg Improvements in and relating to gas heated geysers and water heaters
US3806506A (en) 1971-08-05 1974-04-23 Uniroyal Inc Furan derivatives,compositions thereof and methods for using same
DE3119796A1 (de) 1981-05-19 1982-12-23 Hoechst Ag, 6000 Frankfurt Substituierte tryptaminderivate von thienyloxpropanolaminen, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen sowie ihre verwendung
FR2538388B1 (fr) 1982-12-24 1985-06-21 Pharmuka Lab Nouveaux derives de naphtalene- ou azanaphtalenecarboxamide, leurs procedes de preparation et leur utilisation comme medicaments
US5591761A (en) 1993-05-20 1997-01-07 Texas Biotechnology Corporation Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
PH27357A (en) 1989-09-22 1993-06-21 Fujisawa Pharmaceutical Co Pyrazole derivatives and pharmaceutical compositions comprising the same
GB9012936D0 (en) 1990-06-11 1990-08-01 Fujisawa Pharmaceutical Co Thiophene derivatives,processes for preparation thereof and pharmaceutical composition comprising the same
US5571810A (en) 1990-06-11 1996-11-05 Fujisawa Pharmaceutical Co., Ltd. Thiophene derivatives
IL104311A (en) 1992-02-05 1997-07-13 Fujisawa Pharmaceutical Co Pyrazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
FR2692575B1 (fr) 1992-06-23 1995-06-30 Sanofi Elf Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
JPH084281B2 (ja) 1992-09-30 1996-01-17 橋本コーポレイション株式会社 オンフック後相手の声を拡声する電話装置
FR2728571B1 (fr) 1994-12-22 1997-01-31 Adir Nouveaux ethers d'oximes tricycliques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
US5696151A (en) 1995-11-30 1997-12-09 Uniroyal Chemical Company, Inc. Compounds useful for the inhibition of the replication of HIV-1 and HIV-1 mutants
US6143780A (en) 1999-09-17 2000-11-07 Uniroyal Chemical Company, Inc. N-arylmethylthioanilide compounds useful for the inhibition of the replication of HIV
IL153246A0 (en) 2000-06-28 2003-07-06 Astrazeneca Ab Substituted quinazoline derivatives and their use as inhibitors
JP2005501841A (ja) 2001-08-01 2005-01-20 バセル ポリオレフィン ジーエムビーエイチ 複素環式ペンタレン誘導体の製造方法
WO2003037274A2 (fr) 2001-11-01 2003-05-08 Icagen, Inc. Pyrazole-amides et -sulfonamides
US7005432B2 (en) 2002-05-16 2006-02-28 Hoffman-La Roche Inc. Substituted imidazol-pyridazine derivatives
AU2003265395A1 (en) 2002-08-14 2004-03-03 Ppd Discovery, Inc. Prenylation inhibitors and methods of their synthesis and use
ES2379076T3 (es) 2002-12-02 2012-04-20 Astellas Pharma Inc. Derivados de pirazol útiles como inhibidores de COX-I
US7622471B2 (en) 2003-02-07 2009-11-24 Daiichi Pharmaceutical Co., Ltd. Pyrazole derivatives having a pyridazine and pyridine functionality
TW200423930A (en) * 2003-02-18 2004-11-16 Hoffmann La Roche Non-nucleoside reverse transcriptase inhibitors
DE602004023586D1 (de) 2003-02-27 2009-11-26 Neurosearch As Neue diazabicyclische arylderivate
FR2856683A1 (fr) 2003-06-25 2004-12-31 Sanofi Synthelabo Derives de 4-cyanopyrazole-3-carboxamide, leur preparation et leur application en therapeutique
PL2298743T3 (pl) * 2003-06-26 2013-02-28 Novartis Ag Inhibitory kinaz P38 na bazie 5-członowych heterocykli
GB0315657D0 (en) * 2003-07-03 2003-08-13 Astex Technology Ltd Pharmaceutical compounds
WO2005007625A2 (fr) 2003-07-14 2005-01-27 The University Of Tennessee Research Foundation Amides heterocycliques a activite anti-tuberculinique
FR2860792B1 (fr) 2003-10-10 2006-02-24 Sanofi Synthelabo Derives de thiophene-2-carboxamide, leur preparation et leur application en therapeutique
RU2375349C2 (ru) 2004-02-20 2009-12-10 Астразенека Аб Производные 3-замещенного 1,5-дифенилпиразола, полезные в качестве св1 модуляторов
CN1980912A (zh) 2004-07-01 2007-06-13 第一制药株式会社 吡唑衍生物
GB0417910D0 (en) 2004-08-11 2004-09-15 Novartis Ag Organic compounds
CN101006082B (zh) 2004-08-23 2010-09-29 伊莱利利公司 组胺h3受体药剂、制备方法和治疗用途
DE102004054666A1 (de) 2004-11-12 2006-05-18 Bayer Cropscience Gmbh Substituierte Pyrazol-3-carboxamide, Verfahren zur Herstellung und Verwendung als Herbizide und Pflanzenwachstumsregulatoren
US7612200B2 (en) 2004-12-07 2009-11-03 Locus Pharmaceuticals, Inc. Inhibitors of protein kinases
US7741479B2 (en) 2004-12-07 2010-06-22 Locus Pharmaceuticals, Inc. Urea inhibitors of MAP kinases
MX2007006743A (es) 2004-12-15 2007-07-09 Astrazeneca Ab Ligandos del receptor de acetilcolina nicotinica.
US20110098301A1 (en) 2005-03-10 2011-04-28 Bayer Healthcare Llc Pyrimidine Derivatives for Treatment of Hyperproliferative Disorders
BRPI0612287A8 (pt) 2005-06-27 2019-01-22 Exelixis Inc composição para uso farmacêutico no tratamento de doenças através da medicina nuclear e métodos de uso e para modulação de atividade de receptor nuclear
EP1743637A1 (fr) 2005-07-15 2007-01-17 Laboratorios Del Dr. Esteve, S.A. Utilisation des derivés du pyrazole seuls ou en combinaison pour le traitement du syndrome métabolique
WO2007009701A2 (fr) 2005-07-15 2007-01-25 Laboratorios Del Dr. Esteve, S.A. Utilisation de composes pyrazoliniques substitues pour traiter des facteurs de risque cardiovasculaires imputables a des troubles du metabolisme ou de l'alimentation
GB0516661D0 (en) 2005-08-13 2005-09-21 Astrazeneca Ab Therapeutic agents
WO2008043775A1 (fr) 2006-10-12 2008-04-17 Janssen Pharmaceutica Nv Dérivés de pyrazinone substitués pour une utilisation en tant que médicament
EP2518063B1 (fr) 2006-12-21 2017-02-01 Sloan-Kettering Institute For Cancer Research Composés contenant des pyridazinones et furan
GB0701426D0 (en) 2007-01-25 2007-03-07 Univ Sheffield Compounds and their use
DE102008015033A1 (de) 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituierte (Pyrazolyl-carbonyl)imidazolidinone und ihre Verwendung
DE102008015032A1 (de) * 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituierte Pyrazolamide und ihre Verwendung

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002100853A1 (fr) * 2001-06-04 2002-12-19 F. Hoffmann-La Roche Ag Derives de pyrazole utilises comme inhibiteurs de la transcriptase inverse du vih
WO2004024147A1 (fr) * 2002-09-16 2004-03-25 Pfizer Limited Derives de 4-(3,5-dicyanophenoxy)pyrazole utilises comme modulateurs de la transcriptase inverse dans le traitement, entre autres, du vih
WO2004031178A1 (fr) * 2002-10-07 2004-04-15 Pfizer Limited Derives de pyrazole
US20050054707A1 (en) * 2003-09-05 2005-03-10 Pfizer Inc. Pyrazole derivatives

Also Published As

Publication number Publication date
MX2010010230A (es) 2010-11-09
CA2718685C (fr) 2016-11-29
US20110124618A1 (en) 2011-05-26
AU2009226656A1 (en) 2009-09-24
CL2009000636A1 (es) 2010-05-07
PE20091718A1 (es) 2009-12-11
US8399682B2 (en) 2013-03-19
JP2011514366A (ja) 2011-05-06
CN101977908A (zh) 2011-02-16
ZA201007361B (en) 2011-12-28
EP2254885A1 (fr) 2010-12-01
UY31717A1 (es) 2009-08-31
CN101977908B (zh) 2014-04-23
CA2718685A1 (fr) 2009-09-24
UA102390C2 (ru) 2013-07-10
RU2010141578A (ru) 2012-04-27
JP5576853B2 (ja) 2014-08-20
EP2254885B1 (fr) 2013-12-04
TW200951125A (en) 2009-12-16
IL207649A0 (en) 2010-12-30
MA32224B1 (fr) 2011-04-01
AP2010005422A0 (en) 2010-10-31
DE102008015033A1 (de) 2009-09-24
WO2009115213A1 (fr) 2009-09-24
AR070919A1 (es) 2010-05-12
NZ588141A (en) 2012-05-25
KR20100124337A (ko) 2010-11-26

Similar Documents

Publication Publication Date Title
ZA201007816B (en) Novel substituted pyridin-2-ones and pyridazin-3-ones
IL211042A0 (en) Imidazopyridin-2-one derivatives and uses thereof
IL208063A0 (en) Novel heterocyclic compounds and uses thereof
ZA201103635B (en) Azaquinolinone derivatives and uses thereof
IL210804A (en) Benzylidenehydrazides and their uses
IL211167A0 (en) Substituted pyrrolidine-2-carboxmides
EP2369185A4 (fr) Attache
GB0803352D0 (en) Oligopeptidic compounds and uses thereof
ZA201009073B (en) Heterocyclic compound and use thereof
GB0808575D0 (en) Compilign and linking
IL210773A0 (en) Neuropeptide-2 receptor (y-2r) agonists and uses thereof
IL212364A0 (en) Neuropeptide-2-receptor (y-2r) agonists and uses thereof
EP2291377A4 (fr) Imidazopyrimidinones et leurs utilisations
ZA201103456B (en) Leukolectins and uses thereof
IL208281A0 (en) Substituted cyclohexyldiamines
EP2247601A4 (fr) Thiazopyrimidinones et leurs utilisations
IL209175A0 (en) Substituted qunazolines
AP2774A (en) Substituted (pyrazolylcarbonyl) imidazolidinones and their uses
IL206951A0 (en) 3-alkyl-piperazine derivatives and uses thereof
IL206950A0 (en) Aminopiperidinyl derivatives and uses thereof
PL386758A1 (pl) Pasztet amarantusowy
GB0808857D0 (en) Methdos and uses
GB0821681D0 (en) Content provision
GB0816339D0 (en) Glowbiles clip